Lab Tools

» PCR and biomarkers

Most Recent

image: The Sooner, The Better

The Sooner, The Better

By | July 1, 2014

New approaches to diagnosing bacterial infections may one day allow the identification of pathogens and their antibiotic susceptibility in a matter of hours or minutes.

0 Comments

image: Creative Emulsification

Creative Emulsification

By | November 1, 2012

Enhancing data collection from emulsion PCR reactions: three case studies

0 Comments

image: PCR Usage and Preferences

PCR Usage and Preferences

By | November 1, 2012

Quantitative real-time technology dominates the market today but digital PCR is on the rise.

0 Comments

image: Proteome Portraits

Proteome Portraits

By | August 1, 2012

Innovations in mass spectrometry are making quick, comprehensive, and easy proteome mapping more attainable than ever.

0 Comments

image: Microbiology Goes High-Tech

Microbiology Goes High-Tech

By | June 1, 2012

Out with toothpicks and pipettors; in with automation.

0 Comments

image: SPRead Your Antibody Capabilities

SPRead Your Antibody Capabilities

By | May 1, 2012

Using surface plasmon resonance to improve antibody detection and characterization: four case studies

0 Comments

image: Little Squirts

Little Squirts

By | February 1, 2012

A road map to liquid-handling solutions on the market

0 Comments

image: Vital Signs

Vital Signs

By | April 1, 2011

New frontiers in the search for novel, noninvasive biomarkers

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham